During Tuesday’s Current trade, Shares of Ashland Inc (NYSE:ASH), gain 0.69% to $100.75.
Ashland Inc. (ASH) declared that its board of directors has approved proceeding with a plan to separate Ashland into two independent, publicly traded companies. Announcement follows a comprehensive strategic planning review by the company`s global leadership team to better understand Ashland`s markets, customers and the opportunities for each business to create the most value for shareholders, customers and employees. It also represents the final step in Ashland`s more than decade-long transformation from an oil refiner and marketer to a specialty chemicals company, during which the company completed dozens of acquisitions and divestitures.
The New Ashland
The new Ashland will be a global leader in providing specialty chemical solutions to customers in a wide range of consumer and industrial markets. These markets are presently served by Ashland`s Chemicals Group, comprising Ashland Specialty Ingredients and Ashland Performance Materials. Key markets and applications comprise pharmaceutical, personal care, food and beverage, architectural coatings, adhesives, automotive, construction and energy. Together these businesses generated about $3.6 billion in sales for the 12 months ended June 30, 2015.
The new Ashland will focus on: driving growth in higher-margin, highly differentiated core product lines where the company assists customers succeed; leveraging the innovation pipeline by driving new product introductions; optimizing the business and product portfolio; and taking a disciplined approach to capital investment
Ashland Inc. operates as a specialty chemicals company worldwide. The company’s Specialty Ingredients segment provides products, technologies, and resources for solving formulation and product-performance challenges. It offers solutions using natural, synthetic, and semisynthetic polymers derived from plant and seed extract, cellulose ethers, and vinyl pyrrolidones, in addition to acrylic and polyurethane-based adhesives for consumer and industrial applications.
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT), inclined 5.11% to $28.39, during its current trading session.
PTC Therapeutics International, Ltd., a partner of PTC Therapeutics, Inc. (PTCT), recently declared that Health Canada has initiated their review of the company’s New Drug Submission (NDS) for Translarna™ (ataluren) to treat nonsense mutation dystrophinopathy. The NDS will be reviewed with advance consideration under the Health Canada policy of Notice of Compliance with Conditions (NOC/c).
If approved, Translarna would be the first treatment accessible to patients in Canada that addresses an underlying cause of dystrophinopathy, counting nonsense mutation Duchenne muscular dystrophy (nmDMD).
Health Canada’s NOC/c policy is accessible for promising new drug therapies intended for the treatment, prevention or diagnosis of serious, life-threatening or severely debilitating diseases, or conditions for which no drug is presently marketed in Canada , or that represents a noteworthy improvement in the benefit/risk profile over existing therapies. An NDS reviewed under the advanced consideration NOC/c policy is granted an expedited review in 200 days contrast to standard NDS review of 300 days.
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes.
Sanmina Corp (NASDAQ:SANM), during its Tuesday’s current trading session gained 0.82% to $20.84.
Sanmina Corporation (SANM), a leading integrated manufacturing solutions company, recently declared that its Board of Directors has authorized a stock repurchase program of up to $200 million worth of the Company’s common stock.
The new program will take effect upon completion of the Company’s current program. As of recently, about $18 million remains accessible under the current program approved by the Board in September 2014.
The stock repurchase program has no expiration date. The timing of stock repurchases and the number of shares will depend upon the market conditions and other factors. Share repurchases, if any, will be made in the open market, through 10b5-1 programs or in negotiated transactions off the market. Repurchases under the program may be commenced or suspended at any time without preceding notice.
Sanmina Corporation provides integrated manufacturing solutions, components, products and repair, logistics, and after-market services worldwide. It offers product design and engineering services, counting initial development, detailed design, prototyping, validation, preproduction, and manufacturing design; manufacturing of components, subassemblies, and complete systems; final system assembly and test; direct order fulfillment and logistics, and supply chain administration services; and after-market product service and support.
Finally, Synopsys, Inc. (NASDAQ:SNPS), gained 0.89%, to $46.66.
Synopsys, Inc. (SNPS) declared a comprehensive portfolio of IP optimized to address the security, wireless connectivity, energy-efficient and sensor processing requirements for a wide range of Internet of Things (IoT) applications such as wearables, smart appliances, metering and wireless sensor netoperates. The DesignWare® IP portfolio for the IoT comprises power- and area-efficient logic libraries, memory compilers, non-volatile memory (NVM), data converters, wired and wireless interface IP, security IP, ultra-low power processor cores and an integrated sensor and control IP subsystem. In addition, Synopsys’ embARC Open Software Platform offers online access to open-source and commercial drivers, operating systems and middleware to accelerate development of application software. By providing the industry’s broadest portfolio of IP and software solutions optimized for the IoT, Synopsys enables developers to accelerate development of IoT systems.
Re-architected and Optimized IP Solutions for the IoT
- Near threshold, ultra-high density logic libraries reduce power consumption, while thick oxide logic libraries deliver low leakage for always-on functions.
- High-density, low voltage embedded memory compilers incorporate the smallest bit cells with integrated test and repair supporting embedded flash.
- Power- and area-optimized 12 bit/14-bit SAR data converters, USB 1.1 and 2.0, MIPI CSI-2 and DSI, and NVM IP enable implementation of required sensor, data and connectivity functions, while lowering overall system cost.
- Silicon-proven Bluetooth® Smart IP implements the Bluetooth 4.0, 4.1 and 4.2 low energy standards and supports down to one-volt operation for extended battery life.
Synopsys, Inc. provides electronic design automation (EDA) software products used to design and test integrated circuits and electronic systems in the United States, Europe, Japan, and the rest of Asia Pacific. Its EDA solutions comprise Galaxy Design platform that provides integrated chip design solution; Verification Continuum Platform, which offers virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug; and FPGA design products that are complex chips programmed to perform specific functions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
